Helen Sabzevari - 29 Jun 2026 Form 4 Insider Report for PRECIGEN, INC. (PGEN)

Reporting relationship: President and CEO
Issuer ticker: PGEN
Reported as of: 29 Jun 2026
Net transaction value: -$2,042,864
SEC form: 4
Accepted by SEC: 01 Jul 2026, 18:19:25 UTC
Prior SEC filing: 01 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Helen Sabzevari, by Donald P. Lehr, as attorney-in-fact

Key filing fact

Helen Sabzevari filed Form 4 for PRECIGEN, INC. (PGEN) on 01 Jul 2026.

Key facts

This page summarizes Helen Sabzevari's Form 4 filing for PRECIGEN, INC. (PGEN).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 01 Jul 2026, 18:19.

Change

Previous filing in this sequence was filed on 01 Jun 2026.
Current net transaction value: -$2,042,864.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001724195 Primary reporting owner

Sabzevari Helen

Relationship: President and CEO
Address: 20374 SENECA MEADOWS PARKWAY, GERMANTOWN
Signature: /s/ Helen Sabzevari, by Donald P. Lehr, as attorney-in-fact
Signature date: 01 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PGEN transaction

Common Stock

Options Exercise

Transaction value
Shares: +346,836
Change %: +9.2%
Price: $2.33^*
Shares after: 4,115,708
Date: 29 Jun 2026
Ownership: Direct

PGEN transaction

Common Stock

Sale

Transaction value: $2,042,864
Shares: -346,836
Change %: -8.4%
Price: $5.89
Shares after: 3,768,872
Date: 29 Jun 2026
Ownership: Direct
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PGEN transaction Derivative

Option to Purchase Common Stock (Right to Buy)

Options Exercise

Transaction value
Shares: -346,836
Change %: -41%
Price: $0.000000^*
Shares after: 500,164
Date: 29 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 346,836
Exercise price: $2.33
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 3 footnotes

Footnote F1

Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.75 to $6.04, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Footnote F3

The stock options are fully vested.